Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ZBTB44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SHOX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DENND4C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERBB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101926944 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
BCL2L15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF165 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAV2-IT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
HPSE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MUL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYCE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on